India, over the New Year weekend, has rejected an unmerited HIV drug patent application by US drug giant Abbott Laboratories, paving the way for access to lifesaving medication for HIV patients across the world. Read full story here.
India, over the New Year weekend, has rejected an unmerited HIV drug patent application by US drug giant Abbott Laboratories, paving the way for access to lifesaving medication for HIV patients across the world. Read full story here.
Learn more about how you can help build a more equitable system for all